Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07932314
PHASE3

Prognostic Value of Oxygen-15 Water PET in Coronary Artery Disease

Sponsor: Vastra Gotaland Region

View on ClinicalTrials.gov

Summary

This study evaluates the prognostic value of quantitative myocardial perfusion imaging using oxygen-15 water positron emission tomography in patients with clinically suspected or known coronary artery disease (main basket), and explores temporal changes in myocardial perfusion related to disease progression, underlying pathophysiological processes, or treatment-related effects (additional baskets).

Official title: Prognostic Performance of Quantitative Myocardial Perfusion Imaging Using H2[15O] Positron Emission Tomography in Coronary Artery Disease - The AQUA COR Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40000

Start Date

2026-12

Completion Date

2036-12

Last Updated

2026-11-17

Healthy Volunteers

No

Interventions

DRUG

Oxygen-15 Water

Oxygen-15 water enables absolute quantification of myocardial blood flow at rest and during pharmacological stress using PET. In the main basket, participants will undergo a single quantitative myocardial perfusion imaging examination using oxygen-15 water PET at rest and during pharmacological stress (adenosine or regadenoson). In the additional baskets, the same examination will be performed twice, at baseline and at follow-up. In all baskets, blood samples will be collected when feasible and stored in a biobank for future research.

Locations (1)

Department of Clinical Physiology, Sahlgrenska University Hospital

Gothenburg, Sweden